Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYS-055 for reduction of fatigue
jRCTs031220483Completed
- Sponsor
- Sato Pharmaceutical
- Start
- Dec 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial of SYS-055 in myalgic encephalomyelitis (ME) and asthenia, sponsored by Sato Pharmaceutical. Primary endpoint: Visual analogue scale of fatigue. Started Dec 2022; status: completed.
02
Drugs
SYS-055
03
Conditions
myalgic encephalomyelitis (ME)asthenia
Beyond the preview
Go deeper on jRCTs031220483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220483.